FADD, or Fas-associated death domain protein, plays a pivotal role in the initiation and transduction of apoptotic signals within cells. Its function is intricately tied to death receptor-mediated apoptosis, where it acts as an adaptor protein linking death receptors to downstream effector caspases. Upon engagement of death receptors such as Fas and TNF receptor 1 (TNFR1) by their respective ligands, FADD is recruited to the receptor complex through interactions mediated by its death domain. This recruitment facilitates the assembly of the death-inducing signaling complex (DISC), wherein FADD serves as a platform for the recruitment and activation of procaspase-8 or procaspase-10 through interactions mediated by its death effector domain (DED). Activation of procaspases within the DISC leads to the initiation of the caspase cascade, culminating in apoptotic cell death through the cleavage of key cellular substrates.
The activation of FADD is primarily governed by the engagement of death receptors and subsequent recruitment to the receptor complex. Upon ligand binding to death receptors, conformational changes occur within the receptor complex, enabling the recruitment of FADD through specific protein-protein interactions. This recruitment is facilitated by the death domains present in both FADD and the death receptors, ensuring the proper assembly of the DISC. Once recruited to the DISC, FADD undergoes a conformational change that enables its interaction with procaspases, thereby promoting their activation and the initiation of apoptosis. Additionally, post-translational modifications such as phosphorylation may modulate the activity of FADD, fine-tuning its function in apoptotic signaling pathways. Overall, the activation of FADD is tightly regulated and serves as a critical step in the induction of apoptotic cell death in response to extracellular signals.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Induces apoptosis and activates caspases, promoting FADD recruitment. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Raises intracellular calcium levels, affecting death receptor signaling involving FADD. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Modulates NF-κB signaling, affecting FADD-associated pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates JNK signaling, which can recruit FADD in death receptor pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; influences apoptotic pathways where FADD is operational. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor; impacts JNK signaling which can recruit FADD. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK; affects signaling pathways downstream of FADD. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Affects oxidative stress pathways, influencing FADD's role in apoptosis. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Caspase inhibitor; its use can result in the accumulation of FADD at the DISC. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
ERK inhibitor; alters the MAPK pathway and affects FADD's recruitment in death signaling. | ||||||